Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté
NCT ID: NCT02626377
Last Updated: 2023-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
186 participants
INTERVENTIONAL
2015-10-31
2019-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the Informal Carers of Elderly Cohort is to define, through a longitudinal study of their life course, the profiles of caregivers of patients with a diagnosis of one of the following diseases: cancer (breast, prostate, colon-rectum), neuro-degenerative diseases (Parkinson's disease, Alzheimer's and similar diseases), neuro-vascular diseases (Cerebrovascular Accident (CVA)), Age-related Macular Degeneration(AMD) and heart disease (heart failure), aged ≥ 60 years old and living in Burgundy or Franche-Comte. By following the different phases of the caregiving relationship from the announcement of the diagnosis, it will be possible to assess the quality of life of caregivers and evaluate the implementation of a pragmatic social action to help informal caregivers through a randomized intervention trial nested in the cohort.
Thanks to an analytical and longitudinal definition of the profiles of informal caregivers, this study could gather precise information on their life courses and their health trajectory by identifying the consequences associated with the concept of their role of aid in care. In addition, the randomized intervention trial will explore the efficacy, in terms of quality of life, and efficiency of a social action to support the caregivers. These data will allow to identify strategies that could be used to improve the existing sources of aid and to propose new approaches to help caregivers. This study will provide the opportunity to identify the most relevant means of support and to give an impulse for new healthcare policies.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Formal Home Help on Quality of Life for Caregivers of Elderly Patients With Neurocognitive Impairment
NCT04732312
Developing and Implementing Meaningful Activities Facilitators in Geriatric Short Stay
NCT06080126
Assessment of Teleconsulting in Nursing Homes
NCT02157740
Determinants of Frailty Among of Informal Caregivers of Demented Patient
NCT03994562
Opposition to Diagnostic or Therapeutic Procedures by Aged Hospitalized Patient
NCT03373838
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional arm
'Support provided by social worker'
Support provided by social worker
Caregivers randomized in intervention arm will receive an information booklet (which informs about existing structures and actions) and will receive support provided by a social worker schedule every 6 months during two years. The support duration will be one hour and will be defined as two parts: administration of the LASA questionnaire, and a standardized semi directive interview to assess needs.
Information booklet receipt
Caregivers will only receive an information booklet (which informs about existing structures and actions)
Non-interventional arm
'Information booklet receipt'
Information booklet receipt
Caregivers will only receive an information booklet (which informs about existing structures and actions)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Support provided by social worker
Caregivers randomized in intervention arm will receive an information booklet (which informs about existing structures and actions) and will receive support provided by a social worker schedule every 6 months during two years. The support duration will be one hour and will be defined as two parts: administration of the LASA questionnaire, and a standardized semi directive interview to assess needs.
Information booklet receipt
Caregivers will only receive an information booklet (which informs about existing structures and actions)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* to accept to complete the questionnaire to designate the principal caregiver;
* To live in either Burgundy-Franche-Comte county;
* have been recently diagnosed at hospital or in private-sector for the following diseases: Local or metastatic cancer diagnosed less than 6 month (breast cancer-hormone sensitive- in first line chemotherapy treatment, hormone-sensitive prostate cancer or in metastatic recurrence after 3 years of remission, considered as a new case, colorectal cancer in first line chemotherapy treatment), a neuro-degenerative disease (Parkinson disease diagnosed less than 7 years, Alzheimer disease and similar diseases diagnosed less than 12 months and /or with a Mini Mental State Examination (MMSE)\<24 and \>10 (performed less than 3 mois)), Age-related Macular Degeneration,( geographic atrophy or neovascular, diagnosed less than 12 month with an acuity range between 2 and 6/10e, be at least 65 years old and have received less than 3 sessions of intravitreal injections (IVT)), cardiac disease (heart failure diagnosed less than 3 months), neuro-vascular disease (ischemic or hemorrhagic stroke with clinical evidence of post stroke lesions upper than 24 hours, diagnosed less than 6 months and with a Rankin's score inferior or equal to 2).
* to be a member of the patient's social environment (family, friend and neighbor);
* to be identify by the patient as the "principal caregiver" based on the designation questionnaire or to have complete the self-designation form as a principal caregiver;
* ≥ 18 years old;
* not be an employee of a healthcare organization;
* living in Burgundy-Franche-Comte;
* to be able to complete questionnaires,
Exclusion Criteria
Caregiver
\- to be under guardianship, curatorship or under the protection of justice
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Methodological and quality of life unit in oncology (CHRU de Besançon)
UNKNOWN
University of Franche-Comté
OTHER
University of Burgundy
OTHER
Pôle de Gérontologie Interrégional Bourgogne et Franche-Comté
UNKNOWN
CARSAT Bourgogne et Franche-Comté
UNKNOWN
CCAS of Dijon
UNKNOWN
CCAS of Besançon
UNKNOWN
CCAS of Montbéliard
UNKNOWN
Burgundy Regional Council
UNKNOWN
Franche-Comté Regional Council
UNKNOWN
The Municipality of Besançon
UNKNOWN
The Municipality of Dijon
UNKNOWN
General Council of the Doubs
UNKNOWN
General Council of the Territoire de Belfort
UNKNOWN
Collectif Inter Associatif Sur la Sante Bourgogne
UNKNOWN
Union Régionale Interfédérale des Œuvres et Organismes Privés Sanitaires Bourgogne
UNKNOWN
Association Gérontopôle Pierre Pfitzenmeyer
UNKNOWN
Pôle de compétitivité Vitagora Goût-Nutrition-Santé
UNKNOWN
National Old Age Insurance Fund for Employees (CNAVTS)
OTHER
Sheerbrooke Gérontopôle
UNKNOWN
France Alzheimer
OTHER
Institut Régional de Vieillissement (IRV)
UNKNOWN
Novartis Pharmaceuticals
INDUSTRY
Roche Foundation
UNKNOWN
Ligue contre le cancer, France
OTHER
National Cancer Institute, France
OTHER_GOV
Quality of life and cancer clinical research platform
UNKNOWN
National Research Agency, France
OTHER
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Virginie NERICH, Dr
Role: PRINCIPAL_INVESTIGATOR
Pôle Pharmaceutique CHU de Besançon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Besançon
Besançon, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pozet A, Falcoz A, Roller C, Jai T, Meurisse A, Nerich V. Health-state utility values and their time to deterioration in informal caregivers of older patients with chronic diseases. Front Public Health. 2025 Apr 30;13:1531608. doi: 10.3389/fpubh.2025.1531608. eCollection 2025.
Pozet A, Darnis S, Bonnet M, Meurisse A, Dabakuyo-Yonli TS, Lejeune C, Fagnoni P, Gaimard M, Manckoundia P, Quibel C, Marchand M, Anota A, Nerich V. Quality of Life and Needs in Caregivers: Results From the Prospective Multicentric Open-Label Randomized Study of Informal Caregivers of Elderly Patients. Int J Public Health. 2023 Aug 30;68:1605459. doi: 10.3389/ijph.2023.1605459. eCollection 2023.
Pozet A, Lejeune C, Bonnet M, Dabakuyo S, Dion M, Fagnoni P, Gaimard M, Imbert G, Nerich V, Foubert A, Chotard M, Bonin M, Anota A, Bonnetain F. Evaluation of efficacy and efficiency of a pragmatic intervention by a social worker to support informal caregivers of elderly patients (The ICE Study): study protocol for a randomized controlled trial. Trials. 2016 Nov 3;17(1):531. doi: 10.1186/s13063-016-1622-8.
Related Links
Access external resources that provide additional context or updates about the study.
ICE study results article
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P/2014/231
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.